000 01364 a2200349 4500
005 20250514002727.0
264 0 _c20010809
008 200108s 0 0 eng d
022 _a0269-2813
024 7 _a10.1046/j.1365-2036.2001.00995.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCook, T A
245 0 0 _aThe pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cJul 2001
300 _a887-98 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdrenergic alpha-Agonists
_xpharmacology
650 0 4 _aAnal Canal
_xdrug effects
650 0 4 _aBotulinum Toxins
_xpharmacology
650 0 4 _aCalcium Channel Blockers
_xpharmacology
650 0 4 _aCalcium Channels
_xphysiology
650 0 4 _aFecal Incontinence
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMuscarinic Antagonists
_xpharmacology
650 0 4 _aMuscle Relaxation
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aReceptors, Muscarinic
_xphysiology
700 1 _aBrading, A F
700 1 _aMortensen, N J
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 15
_gno. 7
_gp. 887-98
856 4 0 _uhttps://doi.org/10.1046/j.1365-2036.2001.00995.x
_zAvailable from publisher's website
999 _c11351529
_d11351529